Medicare Enrolled
Dr. Sudhir Aggarwal, M.D., PH.D.
Vascular Neurology Physician · Paoli, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aggarwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aggarwal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aggarwal
Dr. Sudhir Aggarwal is a vascular neurology physician in Paoli, PA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Aggarwal performed 13,551 Medicare services across 1,059 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aggarwal received a total of $48,815 from 87 pharmaceutical and/or device companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in vascular neurology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aggarwal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 3% volume in PA
$48,815 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,551
Medicare services
Top 3% in PA for vascular neurology physician
1,059
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~968 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
8,800 | $5 | $13 |
| Anti-nausea injection (ondansetron/Zofran) | 1,025 | $0 | $20 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
690 | $12 | $36 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
437 | $16 | $47 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
419 | $137 | $313 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
376 | $0 | $35 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
316 | $0 | $13 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
253 | $67 | $182 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
237 | $50 | $156 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
217 | $1 | $13 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
141 | $23 | $69 |
| Electrocardiogram, 1 to 3 leads A test that records the electrical activity of the heart using one to three electrodes placed on the body. |
133 | $4 | $13 |
| New patient office visit, complex (60-74 min) | 114 | $173 | $448 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
99 | $31 | $440 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $88 | $233 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
50 | $28 | $81 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
44 | $104 | $277 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
42 | $46 | $793 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 30 | $65 | $168 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
28 | $173 | $471 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
25 | $28 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.0% high complexity
85.6% medium
8.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$48,815
Total received (2018-2024)
Avg $6,974/year across 7 years
Top 7% in PA for vascular neurology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
632
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,227 (80.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,376 (19.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$211 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,397
2023
$8,764
2022
$14,219
2021
$8,048
2020
$6,480
2019
$1,401
2018
$1,505
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$6,773
PFIZER INC.
$192
Lundbeck LLC
$112
Novartis Pharmaceuticals Corporation
$110
Genentech USA, Inc.
$102
UCB, Inc.
$83
Amneal Pharmaceuticals LLC
$81
Boston Scientific Corporation
$79
Lilly USA, LLC
$71
Eisai Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$55
Merz Pharmaceuticals, LLC
$52
ARGENX US, INC.
$50
Abbott Laboratories
$45
Biogen, Inc.
$44
ACADIA Pharmaceuticals Inc
$42
Celgene Corporation
$40
SK Life Science, Inc.
$38
Otsuka America Pharmaceutical, Inc.
$36
GlaxoSmithKline, LLC.
$30
Exact Sciences Corporation
$29
MITSUBISHI TANABE PHARMA AMERICA, INC.
$28
Kite Pharma, Inc.
$27
Axsome Therapeutics, Inc.
$24
Grifols USA, LLC
$24
Alexion Pharmaceuticals, Inc.
$22
TG Therapeutics, Inc.
$21
CATALYST PHARMACEUTICALS, INC.
$20
Teva Pharmaceuticals USA, Inc.
$20
Averitas Pharma Inc.
$19
REVANCE THERAPEUTICS, INC.
$18
GE HEALTHCARE
$17
CSL Behring
$16
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 84.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$19,685
AbbVie Inc.
$12,323
Allergan, Inc.
$7,051
Biogen, Inc.
$817
UCB, Inc.
$595
Novartis Pharmaceuticals Corporation
$561
Teva Pharmaceuticals USA, Inc.
$506
Biohaven Pharmaceutical Holding Company Ltd.
$473
Sunovion Pharmaceuticals Inc.
$388
Amgen Inc.
$330
ACADIA Pharmaceuticals Inc
$317
Genentech USA, Inc.
$301
GENZYME CORPORATION
$289
Lilly USA, LLC
$254
PFIZER INC.
$241
Neurocrine Biosciences, Inc.
$218
Alexion Pharmaceuticals, Inc.
$203
Lundbeck LLC
$202
Medtronic, Inc.
$201
Avanir Pharmaceuticals, Inc.
$184
Biohaven Pharmaceuticals, Inc.
$179
CSL Behring
$171
Allergan Inc.
$161
Acorda Therapeutics, Inc
$157
Amneal Pharmaceuticals LLC
$146
Janssen Pharmaceuticals, Inc
$143
Adamas Pharmaceuticals, Inc.
$127
SK Life Science, Inc.
$125
Abbott Laboratories
$118
Regeneron Healthcare Solutions, Inc.
$116
Takeda Pharmaceuticals U.S.A., Inc.
$102
PORTOLA PHARMACEUTICALS, INC.
$100
Eisai Inc.
$99
Mitsubishi Tanabe Pharma America, Inc.
$96
Merz Pharmaceuticals, LLC
$95
Boston Scientific Corporation
$95
ARGENX US, INC.
$82
MDD US Operations, LLC
$76
EMD Serono, Inc.
$75
Sumitomo Pharma America, Inc.
$73
Merz North America, Inc.
$71
MITSUBISHI TANABE PHARMA AMERICA, INC.
$69
Medtronic USA, Inc.
$69
Impax Laboratories, Inc.
$61
Otsuka America Pharmaceutical, Inc.
$53
Neurelis, Inc.
$52
Kyowa Kirin, Inc.
$49
GlaxoSmithKline, LLC.
$48
AstraZeneca Pharmaceuticals LP
$41
GE HealthCare
$40
Celgene Corporation
$40
Philips Electronics North America Corporation
$36
GE HEALTHCARE
$33
US WorldMeds, LLC
$33
PORTOLA PHARMACEUTICALS, LLC
$31
Exact Sciences Corporation
$29
E.R. Squibb & Sons, L.L.C.
$28
Kite Pharma, Inc.
$27
Corium, LLC
$27
Zyla Life Sciences, Inc.
$26
SANOFI-AVENTIS U.S. LLC
$25
Greenwich Biosciences, Inc.
$24
Axsome Therapeutics, Inc.
$24
Grifols USA, LLC
$24
IDORSIA PHARMACEUTICALS US INC
$23
UPSHER-SMITH LABORATORIES LLC
$23
TG Therapeutics, Inc.
$21
CATALYST PHARMACEUTICALS, INC.
$20
Averitas Pharma Inc.
$19
TG THERAPEUTICS, INC.
$19
Assertio Therapeutics, Inc.
$19
LivaNova USA, Inc.
$18
MACROGENICS, INC.
$18
KCI USA, Inc
$18
REVANCE THERAPEUTICS, INC.
$18
Xeris Pharmaceuticals, Inc.
$18
Medtronic Vascular, Inc.
$17
Portola Pharmaceuticals, LLC
$16
Portola Pharmaceuticals, Inc.
$16
Currax Pharmaceuticals LLC
$14
Ultragenyx Pharmaceutical Inc.
$13
Bausch Health US, LLC
$13
W. L. Gore & Associates, Inc.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Banner Life Sciences, LLC
$12
BOSTON SCIENTIFIC CORPORATION
$12
GRT US Holding, Inc.
$7
Top 3 companies account for 80.0% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Activase · Aimovig · Austedo XR · Auvelity · Azstarys · BAFIERTAM · BEVYXXA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · COPAXONE · CYCLOSET · Cambia · Cologuard Collection Kit · DAXXIFY · DUOPA · ELIQUIS · ELITEK · EMGALITY · EVENITY · Epidiolex · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · General - DBS · HYQVIA · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · Leqembi · MARGENZA · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA XSAIL · ONZETRA Xsail · OPDIVO · Ocrevus · Ongentys · PANZYGA · PEDIARIX · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Ponvory · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SARCLISA · SOLIRIS · SPINRAZA · SPRIX · Soliris · Solitaire · TECFIDERA · TOSYMRA · TRELEGY ELLIPTA · TRUMENBA · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · VAC VERAFLO CLEANSE CHOICE · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XARELTO · XEOMIN · Xadago · Xeomin · Yescarta · ZAVZPRET · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in vascular neurology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for vascular neurology physician in PA.
Geographic Context
Vascular neurology physicians within 10 mi
14
Per 100K population
2.6
County median income
$123,041
Nearest hospital
PAOLI HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aggarwal is a mixed practice specialist, with above-average Medicare volume (top 3% in PA), with speaking/promotional industry engagement in the top 7% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aggarwal experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Aggarwal performed 8,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aggarwal receive payments from pharmaceutical companies?
Yes. Dr. Aggarwal received a total of $48,815 from 87 companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aggarwal's costs compare to other vascular neurology physicians in Paoli?
Dr. Aggarwal's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aggarwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Vascular Neurology Physicians in Paoli
Browse vascular neurology physicians in Paoli ranked by procedure volume and transparency data.
Highest volume
Top Vascular Neurology Physicians in PA
Vascular neurology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Vascular Neurology Physicians in PA
Which PA vascular neurology physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology